rethinkPeptides Search
Menu
Study breakdown

Six New Blood Pressure-Lowering Peptides Found in Yellow Croaker Fish Using AI-Guided Screening

In VitroPreliminary evidence
The takeaway

Researchers used a combined computational and laboratory approach to identify six novel ACE-inhibitory peptides from yellow croaker fish protein, with IC50 values as low as 0.63 μM — comparable to pharmaceutical ACE inhibitors.

IC50 of 0.63 μM

The most potent fish-derived peptide showed ACE inhibition comparable to pharmaceutical-grade inhibitors

What the researchers found

Six novel ACE-inhibitory peptides were identified from yellow croaker protein with IC50 values ranging from 0.63 to 10.26 μM. Three peptides (IPYADFK, FYEPFM, NWPWMK) maintained activity after simulated gastrointestinal digestion.

Why it matters

Finding potent natural ACE inhibitors from food sources could lead to functional foods or nutraceuticals that help manage blood pressure with fewer side effects than pharmaceutical drugs.

The numbers in context

Multiple ACE-inhibitory peptides were identified from Larimichthys crocea protein using the combined computational and experimental pipeline.

How the study worked

Combined in silico hydrolysis, QSAR modeling, LC-MS/MS identification, inhibition kinetics, and molecular docking to screen, identify, and validate ACE-inhibitory peptides from Larimichthys crocea protein.

Who was studied

In vitro and in silico analysis of yellow croaker (Larimichthys crocea) protein

What this study cannot tell us

In vitro and in silico study only — no animal or human testing. Gastrointestinal simulation may not fully replicate real digestion. Bioavailability after absorption is unknown. Practical application as food product not yet developed.

How to read the evidence

Preliminary evidence — in vitro and computational study identifying candidate peptides. No animal or human validation yet.

When this study was published

Published in 2024, using current computational biology methods for peptide discovery.

The bigger picture

Food-derived bioactive peptides are an expanding field bridging nutrition and pharmacology. As computational tools improve, the discovery pipeline for natural ACE inhibitors is accelerating, potentially yielding functional foods that complement blood pressure management.

Questions still open

  • Can these peptides survive absorption and reach the bloodstream in active form?
  • Would consuming yellow croaker fish protein hydrolysate produce measurable blood pressure reduction in humans?
  • How do these peptides compare in potency and bioavailability to peptides from other food sources like milk or soy?

Common questions

Could eating yellow croaker fish lower blood pressure?
The peptides were isolated from enzymatically digested fish protein, not from simply eating the fish. Whether enough active peptide survives normal cooking and digestion to affect blood pressure in humans is not yet known.
How do these fish peptides compare to blood pressure medications?
The most potent peptide had an IC50 of 0.63 μM, which is in the range of some pharmaceutical ACE inhibitors. However, in vitro potency doesn't guarantee effectiveness in the body, and these peptides haven't been tested in animals or humans.

Read the original research

Biodirected Screening and Preparation of Larimichthys crocea Angiotensin-I-Converting Enzyme-Inhibitory Peptides by a Combined In Vitro and In Silico Approach.

Molecules (Basel, Switzerland), 29(5)

Citation

Yang, Zhizhi; Wang, Changrong; Huang, Baote; Chen, Yihui; Liu, Zhiyu; Chen, Hongbin; Chen, Jicheng. (2024). Biodirected Screening and Preparation of Larimichthys crocea Angiotensin-I-Converting Enzyme-Inhibitory Peptides by a Combined In Vitro and In Silico Approach.. Molecules (Basel, Switzerland), 29(5). https://doi.org/10.3390/molecules29051134